Clinical Trials Sponsored by Eagle Research Center

Total 12895 results

Providence Cancer Center, Earle A. Chiles Research...

Completed

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute

Recruiting

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute

Withdrawn

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Metastatic Melanoma | Head and Neck Squamous Cell Carcinoma

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute

Active, not recruiting

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma

United States
Providence Cancer Center, Earle A. Chiles Research...
National Cancer Institute (NCI)

Completed

Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma

Melanoma (Skin)

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Robert W. Franz...

Completed

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Locally Advanced Pancreatic Adenocarcinoma

United States
Providence Health & Services
Sanofi; Providence Cancer Center, Earle A. Chiles Research Institute

Terminated

Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer

Non-small-Cell Lung Carcinoma

United States
Rachel Sanborn
AstraZeneca; Providence Cancer Center, Earle A. Chiles Research Institute

Active, not recruiting

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Lung Cancer | Non-small Cell Carcinoma

United States
UbiVac
Providence Health & Services; Providence Cancer Center, Earle A. Chiles Research... and other collaborators

Completed

Pilot Study of DRibble Vaccine for Prostate Cancer Patients (DRibble)

Adenocarcinoma of the Prostate

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Center for Outcomes...

Suspended

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

COVID-19 | Corona Virus Infection | SARS-CoV-2 | 2019-nCoV | 2019 Novel Coronavirus

United States
Providence Health & Services
MedImmune LLC; Providence Cancer Center, Earle A. Chiles Research Institute

Active, not recruiting

Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma

Melanoma | Head and Neck Cancer | Carcinoma, Squamous Cell | Head and Neck Squamous Cell Carcinoma | Cell Cancer, Squamous

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Cell Genesys

Unknown

GVAX in Advanced Prostate Cancer Patients Made Lymphopenic

Prostate Cancer

United States
Aegle Therapeutics
Congressionally Directed Medical Research Programs

Recruiting

Safety of Extracellular Vesicles for Burn Wounds

Burns

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Galecto Biotech... and other collaborators

Recruiting

GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

Metastatic Melanoma | Head and Neck Squamous Cell Carcinoma

United States
Providence Health & Services
MedImmune LLC; Providence Cancer Center, Earle A. Chiles Research Institute; Robert...

Completed

Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions (OX40 Breast)

Metastatic Breast Cancer | Lung Metastases | Liver Metastases

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...

Completed

Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Providence Health & Services
Merck Sharp & Dohme LLC; Providence Cancer Center, Earle A. Chiles Research...

Active, not recruiting

MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
Linnea Polgreen
Fraternal Order of the Eagles Diabetes Research Center

Recruiting

Diabetic Foot Ulcer Imaging- Study 2

Foot Ulcer | Foot Ulcer, Diabetic

United States
Cancer Research and Biostatistics Clinical Trials...
Novartis Pharmaceuticals; University of Arizona; Providence Cancer Center, Earle...

Completed

Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer

Non Small Cell Lung Cancer

United States
Research Center Borstel
German Cancer Research Center

Completed

Evaluation of a LAM FLISA for the Diagnosis of Tuberculosis (LAM FLISA)

Tuberculosis

Germany
German Cancer Research Center

Recruiting

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Early-stage Breast Cancer

Germany
German Cancer Research Center

Not yet recruiting

Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia (NAKIP-AML)

Acute Myeloid Leukemia
German Cancer Research Center

Recruiting

AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma (AMPLIFY-NEOVAC)

Malignant Glioma

Germany
German Cancer Research Center

Completed

Reduction of Cancer Related Fatigue in Patients During TKI Therapy (RECAP)

All Tumor Entities Treated With TKI Therapy

Germany
UbiVac
National Cancer Institute (NCI); Mayo Clinic; Louisiana State University Health... and other collaborators

Completed

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
German Cancer Research Center

Active, not recruiting

Fatigue Prevalence, Severity, and State of Treatment in Germany (FiX)

Cancer-related Fatigue

Germany
German Cancer Research Center

Completed

Testing for COVID-19 Infection in Asymptomatic Persons

COVID-19 Infection

Germany
German Cancer Research Center

Completed

Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis

Inflammation | Breast Cancer | Lifestyle | Hormone Therapy | Breast Cancer Mortality | Inflammatory Biomarkers | Breast Cancer Survival | Postmenopausal Breast Cancer | Genetic Factors | Phytoestrogens
Situs Cancer Research Center

Suspended

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Sarcoma | Adenocarcinoma | Carcinoma | Multiple Myeloma | Desmoplastic Small Round Cell Tumor

United States
German Cancer Research Center

Recruiting

FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer (CoRe_CC-3)

Colorectal Cancer

Germany
German Cancer Research Center

Not yet recruiting

Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head (ASAP)

Pancreatic Cancer Resectable
German Cancer Research Center

Recruiting

CRAFT: The NCT-PMO-1602 Phase II Trial

Metastatic or Locally Advanced Malignancies

Germany
German Cancer Research Center

Completed

Red Meat, Increased Iron Load and CVD Risk

Myocardial Infarction | Stroke | Cardiovascular Mortality

Germany
German Cancer Research Center

Terminated

Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer (HIL)

Non-small Cell Lung Cancer

Germany
1st Allergy & Clinical Research Center

Completed

Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens

Atopic Dermatitis

United States
Blokhin's Russian Cancer Research Center

Recruiting

The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Esophageal Cancer

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy

Melanoma

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III) (IRIGA)

Gastric Carcinoma Stage IV | Esophagogastric Junction Adenocarcinoma Stage IV

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma (RusGCG-01)

Stomach Neoplasms | Gastrointestinal Neoplasms | Docetaxel | Oxaliplatin | Fluoruracil | Irinotecan Hydrochloride

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

Neoplasms | Carcinoma | Carcinoma, Squamous Cell | Neoplasms, Squamous Cell | Anus Neoplasms | Anus Diseases
Blokhin's Russian Cancer Research Center

Recruiting

3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors

Surgery | Implant Site Reaction | Sarcoma of Bone | Chest Wall Tumor | Tumor of Bone | Chest Wall Sarcoma

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer (RuCorT-01)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Blokhin's Russian Cancer Research Center

Not yet recruiting

A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors (RFAdesmoid)

Desmoid Fibromatosis | Desmoid Tumor | Desmoid

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection (ProMeLAR)

Rectal Cancer | Surgery | Neoplasms Malignant | Hernia Incisional

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia (NEMO)

Breast Cancer | Neoadjuvant Endocrine Therapy

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

Sarcoma | Neoplasms, Connective and Soft Tissue | Osteosarcoma | Neoplasms, Connective Tissue | Sarcoma of Bone

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy

Sarcoma | Soft Tissue Sarcoma

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Breast Cancer Stage IV

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer (RuCorT-03)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer (RuCorT-02)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation

Clinical Trials Sponsored by Eagle Research Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations